Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid’s Shares Rise 12.3 Percent; Sequenom Drops 10.2 Percent

Shares of Cepheid rose 12.3 percent for the five-day trading week ended Tuesday. Last week, the firm said that it had received European clearance and began marketing its Xpert MRSA/SA-Blood Cultures and Xpert MRSA/SA-Skin and Soft Tissue Infection SSTI molecular diagnostic tests.
 
Cepheid led all gainers in the BCW Index for the tracking period. Third Wave Technologies, which received the CE Mark for its human papillomavirus molecular diagnostic test last week (see Briefs, this issue), posted an 11.7 percent gain for the week.
 
Sequenom led decliners for the week with a drop of 10.1 percent.
 
Overall, the Index was up .2 percent, while the Dow Jones Industrial Average, despite a sharp decline following the federal bank’s decision to cut interest rates a quarter of a point, closed up 1.4 percent for the tracking period. The Nasdaq gained 1.2 percent and the Nasdaq Biotech Index slipped .1 percent for the week.
 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 11, 2007)
Last
Price
(December 4, 2007)
% change
Affymetrix
AFFX
21.66 20.63 4.99
Agilent
A
36.47 37.48 -2.69
Applied Biosystems
ABI
34.07 34.07 0.00
Beckman
BEC
73.47 69.58 5.59
Becton Dickinson
BDX
82.39 80.38 2.50
Bio-Rad
BIO
101.30 97.55 3.84
Bruker
BRKR
12.07 12.15 -0.66
Caliper
CALP
5.67 5.63 0.71
Cepheid
CPHD
24.30 21.63 12.34
Illumina
ILMN
56.45 56.66 -0.37
Invitrogen
IVGN
93.65 96.37 -2.82
Luminex
LMNX
15.13 15.56 -2.76
MDS
MDZ
19.43 19.99 -2.80
Millipore
MIL
75.68 80.06 -5.47
PerkinElmer
PKI
25.16 26.43 -4.81
Qiagen
QGEN
21.99 21.68 1.43
Sequenom
SQNM
7.80 8.68 -10.14
Sigma-Aldrich
SIAL
53.46 52.75 1.35
Thermo
TMO
57.43 57.27 0.28
Third Wave
TWTI
8.69 7.78 11.70
Waters
WAT
77.94 79.97 -2.54
BCW Index Average 43.06 42.97
0.21

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more